A. Rahn

543 total citations
22 papers, 432 citations indexed

About

A. Rahn is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A. Rahn has authored 22 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A. Rahn's work include Advanced Radiotherapy Techniques (6 papers), Cancer survivorship and care (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A. Rahn is often cited by papers focused on Advanced Radiotherapy Techniques (6 papers), Cancer survivorship and care (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A. Rahn collaborates with scholars based in Germany and United States. A. Rahn's co-authors include Frank Lohr, Frederik Wenz, Stephan Mose, H. Wertz, H.D. Böttcher, Judit Boda‐Heggemann, Irenäus A. Adamietz, Barbara Dobler, Luther W. Brady and Brigitte Taborski and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer and Radiotherapy and Oncology.

In The Last Decade

A. Rahn

20 papers receiving 418 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A. Rahn 226 202 173 119 75 22 432
M.M. Dominello 187 0.8× 258 1.3× 211 1.2× 100 0.8× 82 1.1× 96 540
Stefan Dinges 249 1.1× 164 0.8× 235 1.4× 78 0.7× 156 2.1× 35 591
Clayton B. Hess 113 0.5× 204 1.0× 237 1.4× 169 1.4× 72 1.0× 35 554
Stefano Schipani 185 0.8× 305 1.5× 363 2.1× 192 1.6× 85 1.1× 36 668
Brent Chesson 217 1.0× 231 1.1× 283 1.6× 72 0.6× 75 1.0× 24 442
Sidney Davis 168 0.7× 105 0.5× 276 1.6× 227 1.9× 71 0.9× 27 589
D. Arpin 181 0.8× 309 1.5× 415 2.4× 214 1.8× 72 1.0× 43 687
J. McAleese 132 0.6× 202 1.0× 282 1.6× 95 0.8× 77 1.0× 48 478
B.R. Mancini 155 0.7× 176 0.9× 268 1.5× 148 1.2× 88 1.2× 39 480
Theodore J. Robnett 146 0.6× 181 0.9× 407 2.4× 138 1.2× 39 0.5× 9 518

Countries citing papers authored by A. Rahn

Since Specialization
Citations

This map shows the geographic impact of A. Rahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rahn more than expected).

Fields of papers citing papers by A. Rahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rahn. The network helps show where A. Rahn may publish in the future.

Co-authorship network of co-authors of A. Rahn

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rahn. A scholar is included among the top collaborators of A. Rahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rahn. A. Rahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abo‐Madyan, Yasser, Martin Poledník, A. Rahn, et al.. (2008). Improving Dose Homogeneity in Large Breasts by IMRT. Strahlentherapie und Onkologie. 184(2). 86–92. 29 indexed citations
2.
Poledník, Martin, A. Rahn, Frank Schneider, et al.. (2008). Improving dose homogeneity in large breasts by IMRT – efficacy and dosimetric accuracy of different techniques. European Journal of Cancer Supplements. 6(7). 143–143. 14 indexed citations
3.
Boda‐Heggemann, Judit, et al.. (2007). Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT. Radiotherapy and Oncology. 85(3). 418–423. 87 indexed citations
4.
Boda‐Heggemann, Judit, Sabine Mai, Beate Küpper, et al.. (2006). IGRT: Image guidance in radiation oncology. A review from planar x-ray based positioning to cone beam CT. Der Onkologe. 12(4). 365–372. 4 indexed citations
5.
Boda‐Heggemann, Judit, et al.. (2006). Repositioning accuracy of two different mask systems—3D revisited: Comparison using true 3D/3D matching with cone-beam CT. International Journal of Radiation Oncology*Biology*Physics. 66(5). 1568–1575. 83 indexed citations
6.
Boda‐Heggemann, Judit, Sabine Mai, Beate Küpper, et al.. (2006). IGRT: Bildgesteuerte Strahlentherapie. Der Onkologe. 12(4). 365–372. 5 indexed citations
7.
Rahn, A., et al.. (2003). Schmerz bei brusterhaltend operierten und bestrahlten Brustkrebspatientinnen - Status und Verlauf. Zentralblatt für Gynäkologie. 125(1). 23–29. 1 indexed citations
8.
Mose, Stephan, et al.. (2003). Radiation Enhancement by Gemcitabine-Mediated Cell Cycle Modulations. American Journal of Clinical Oncology. 26(1). 60–69. 25 indexed citations
9.
Rahn, A., et al.. (2001). Palliative Radiochemotherapie mit Bendamustin bei fortgeschrittenen Tumorrezidiven im HNO-Bereich. Strahlentherapie und Onkologie. 177(4). 189–194. 8 indexed citations
10.
Mose, Stephan, et al.. (2001). Influence of irradiation on therapy-associated psychological distress in breast carcinoma patients. International Journal of Radiation Oncology*Biology*Physics. 51(5). 1328–1335. 39 indexed citations
11.
Mose, Stephan, et al.. (2001). Enhancement of radiation effect by gemcitabine-mediated cell cycle modulations. International Journal of Radiation Oncology*Biology*Physics. 51(3). 188–188.
12.
Mose, Stephan, et al.. (2000). Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines.. PubMed. 20(1A). 401–5. 22 indexed citations
13.
Mose, Stephan, et al.. (2000). Wertigkeit der Radiotherapie in der Behandlung des multiplen Myeloms. Strahlentherapie und Onkologie. 176(11). 506–512. 28 indexed citations
14.
Mose, Stephan, et al.. (1999). VerstÄrkung der radiotherapeutischen wirkung auf HeLa-Zellen durch gemcitabine. Strahlentherapie und Onkologie. 175(2). 78–83. 22 indexed citations
15.
Mose, Stephan, et al.. (1999). Einfluß der adjuvanten radiotherapie auf das psychische befinden von patientinnen mit einem brusterhaltend operierten mammakarzinom. Strahlentherapie und Onkologie. 175(3). 112–118. 11 indexed citations
16.
Taborski, Brigitte, et al.. (1999). Different radiosensitizing effects of Gemcitabine in human squamous cell carcinoma cell lines. European Journal of Cancer. 35. S184–S184. 1 indexed citations
17.
Rahn, A., Richard P. Baum, Irenä us A. Adamietz, et al.. (1998). Stellenwert der18F-Fluordeoxyglucose-Positronen-emissionstomographie in der Radiotherapieplanung von Kopf-Hals-Tumoren. Strahlentherapie und Onkologie. 174(7). 358–364. 26 indexed citations
18.
Rahn, A., et al.. (1998). Influence of radiotherapy on psychological health in breast cancer patients after breast conserving surgery.. PubMed. 18(3C). 2271–3. 14 indexed citations
19.
Rahn, A., et al.. (1995). 595 Pronounced dermatological side effects following irradiation (RT) given with interferon alpha-2A (IFN) plus retinoic acid (RA). European Journal of Cancer. 31. S126–S126. 1 indexed citations
20.
Rahn, A. & G Börsch. (1988). [Recurrent ulcers following stomach resection in Billroth II and Billroth I stomachs. Different patterns of distribution].. PubMed. 83(16). 503–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026